Agree. Money talks in any business. If anyone can come up with 20 million grand and lay it on the line, there will be pills shooting out from the factory in a heartbeat. It's unfortunate that the previous administration has all but drained the otherwise valuable resources still available. Creditors are generally more business-minded than being visionary. They would prefer to see money back in their pockets than risking their necks for any visionary mission. However, given that there is little choice left, they might opt for some sort of compromise just to let us stand a chance to pay them back.
Yes, producing the quality drug, distributing it, marketing it, billing $ collecting the money and to oversee that the revenue is used properly need someone to administer the entire process. XN needs someone like Monty to kick start the entire process properly. That, I believe, is the main reason why XN does not want some foreman to just take over. The complexity calls for a dedicated CEO to get the job done.
XN has every reason to benefit from XI to be relicensed due to the marketing potential in the USA and worldwide. From the track record point of view, XN would not look very good in the world stage by severing the head of the parent company and then selling their image as a company with ethical business practice. I think XN would rather have a much larger stake (share) of the new company instead of bypassing us altogether.
News 
Market Data 
Discover 
